Degirmenci, M. Et Al. 2016. Octreotide in combination with AT-101 induces cytotoxicity and apoptosis through up-regulation of somatostatin receptors 2 and 5 in DU-145 prostate cancer cells. Tumor Biology , vol.37, no.4 , 4939-4944.

Degirmenci, M., Erdogan, A. P., Bulut, G., ATMACA İLHAN, H., Uzunoglu, S., Karaca, B., ... Karabulut, B.(2016). Octreotide in combination with AT-101 induces cytotoxicity and apoptosis through up-regulation of somatostatin receptors 2 and 5 in DU-145 prostate cancer cells. Tumor Biology , vol.37, no.4, 4939-4944.

Degirmenci, Mustafa Et Al. "Octreotide in combination with AT-101 induces cytotoxicity and apoptosis through up-regulation of somatostatin receptors 2 and 5 in DU-145 prostate cancer cells," Tumor Biology , vol.37, no.4, 4939-4944, 2016

Degirmenci, Mustafa Et Al. "Octreotide in combination with AT-101 induces cytotoxicity and apoptosis through up-regulation of somatostatin receptors 2 and 5 in DU-145 prostate cancer cells." Tumor Biology , vol.37, no.4, pp.4939-4944, 2016

Degirmenci, M. Et Al. (2016) . "Octreotide in combination with AT-101 induces cytotoxicity and apoptosis through up-regulation of somatostatin receptors 2 and 5 in DU-145 prostate cancer cells." Tumor Biology , vol.37, no.4, pp.4939-4944.

@article{article, author={Mustafa Degirmenci Et Al. }, title={Octreotide in combination with AT-101 induces cytotoxicity and apoptosis through up-regulation of somatostatin receptors 2 and 5 in DU-145 prostate cancer cells}, journal={Tumor Biology}, year=2016, pages={4939-4944} }